Lack of knowledge and understanding
Clinical guidelines for FDA-approved GLP-1/GIP therapies generally include adults with obesity (BMI 30) or overweight (BMI 27) with weight-related conditions such as type 2 diabetes or high blood pressure
Acarbose competitively inhibits -glucosidase in the cells of the small intestinal wall, preventing the breakdown of starch into disaccharides and further conversion into monosaccharides
At Spectrum Healthcare, we are committed to leading in integrative medicine research and providing our patients with the most current, honest, and balanced advice available
By replenishing NAD+ levels, this treatment helps combat fatigue, improve cognitive function, and slow the effects of aging
FAQ Spotlight: How FuturHealth frames legitimacy Enrollment enables staged review, with clinician judgment and pharmacy licensing providing verification only after intake access and authorization occur